Regulation vs. Innovation
(Health Cities Days)
As part of the Health Cities Days , the Health Cities project’s study visit under Interreg Europe, on 29 October the partners visited Roche Diagnostics headquarters in Sant Cugat, member of Sant Cugat is BIVA*
Jacques Baudin, Head Go-To-Market & Customer Success EMEA–LATAM, Roche Diagnostics España Information Solutions, highlighted the value of clinical diagnostics and the ethical and regulated use of Artificial Intelligence (AI) as key elements in transforming healthcare systems. AI can accelerate clinical decision-making and improve result accuracy — always within a robust regulatory framework and under human supervision — empowering healthcare professionals rather than replacing them.
Dr Josep Quer (Vall d’Hebron Institute of Research (VHIR) – Vall d’Hebron Institut de Recerca) presented the translational research model aimed at bringing biomedical research outcomes into clinical practice. He illustrated it with the hepatitis C project, which uses next-generation sequencing (NGS) tools to raise the cure rate to 95%, thanks to collaboration between research, hospitals and industry. He emphasised that innovation only makes sense when it benefits patients and society.
An inspiring closing session that showed how collaboration between research and industry can pave the way towards a more personalised, digital and ethical health system.
Who promotes the Innovation Alliance
The alliance is made up of local and regional public bodies, global innovation centers from different sectors, business associations, and universities and technology and science centers in the region.
